Data / Form D filings / VAXINNATE CORP
VAXINNATE CORP: Form D filings
VAXINNATE CORP, a biotechnology company in Cranbury, NJ, filed 7 Form D notices with the SEC between 2009 and 2015. The latest, on September 28, 2015, reports $3.2 million sold of a $4.3 million offering to 14 investors.
Find out what VAXINNATE CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 CEDAR BROOK DRIVE, Cranbury, NJ, 08512
- Phone
- (609) 860-2260
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1174224
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2015 | New notice | $4,341,507 | $3,248,047 | $1,093,460 | 14 | Sep 18, 2015 | sec.gov |
| Oct 2, 2014 | New notice | $6,265,125 | $6,000,000 | $265,125 | 9 | Sep 25, 2014 | sec.gov |
| Feb 24, 2012 | Amendment | $24,969,925 | $24,810,408 | $159,517 | 13 | Mar 17, 2010 | sec.gov |
| Apr 8, 2011 | Amendment | $21,927,703 | $21,698,759 | $228,944 | 12 | Mar 17, 2010 | sec.gov |
| Feb 15, 2011 | Amendment | $16,857,334 | $16,679,752 | $177,582 | 12 | Mar 17, 2010 | sec.gov |
| Mar 19, 2010 | New notice | $15,623,377 | $5,207,792 | $10,415,585 | 12 | Mar 17, 2010 | sec.gov |
| May 19, 2009 | New notice | $31,000,000 | $15,000,000 | $16,000,000 | 12 | May 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Philippe O. Chambon | Director | |
| Thomas A. Monath | Director | |
| Wayne Pisano | Executive Officer, Director | |
| David O. Williams | Director | |
| Sam O. Wu | Director | |
| Augustine O. Lawlor | Director | |
| Lynda A. Tussey | Executive Officer | |
| Kathleen A. McGowan | Executive Officer | |
| Timothy O. Shannon | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Sep 28, 2015 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VAXINNATE CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.